Problems with nomenclature and pharmacodynamics in trophoblastic disease.
Kohorn
Ernest I
EI
D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage / Q000494:pharmacology; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D006063:Chorionic Gonadotropin / Q000097:blood*; D019008:Drug Resistance, Neoplasm; D005260:Female; D006801:Humans; D002955:Leucovorin / Q000008:administration & dosage / Q000494:pharmacology; D008727:Methotrexate / Q000008:administration & dosage / Q000494:pharmacology; D009367:Neoplasm Staging; D011247:Pregnancy; D009626:Terminology as Topic; D014328:Trophoblastic Neoplasms / Q000145:classification* / Q000188:drug therapy* / Q000473:pathology; D014594:Uterine Neoplasms / Q000145:classification* / Q000188:drug therapy* / Q000473:pathology
D000964:Antimetabolites, Antineoplastic; D006063:Chorionic Gonadotropin; D002955:Leucovorin; D008727:Methotrexate